flow trial semaglutide renal outcomes 2024 chronic kidney disease results Kidney With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes Kidney and Survival Outcomes with – flow trial semaglutide kidney outcomes

How to Adjust Weight Loss Goals on GLP-1 Medications Losing weight on GLP-1 medications like Wegovy or Ozempic isnt just about hitting a number on the scale its about tracking overall health and making adjustments along the way

Wehrenberg WB, Wiviott SD, Voltz DM, Giustina A

For instance, patients using higher doses semaglutide at 2 mg or more and tirzepatide at 10 mg or more lost an average of 14.7 kg (roughly 32.4 lbs) over nine months

Verma S, Butler J, Borlaug BA, et al

What factors might influence the severity of symptoms in a GLP-1 agonist overdose, and how can understanding these factors improve the management of such cases

The combination of Ozempic's gastrointestinal side effects with cannabis use could potentially exacerbate nausea or make it difficult to distinguish between medication side effects and cannabis-related symptoms